Management of LDL cholesterol or non-HDL cholesterol is important to reduce the risk of future cardiovascular events in adults with existing cardiovascular disease. High-intensity statins are the most ...

BARCELONA, Spain—(UPDATED) Aspirin has long been the antiplatelet of choice for long-term secondary prevention in patients with coronary disease, but a meta-analysis of several trials suggests P2Y12 ...

A recent survey of nearly 100 employers regarding their worker’s compensation policies and practices, conducted by Occupational Health & Safety and Injury Management Partners LLC, demonstrated some ...

Aspirin continues to be underused as a means of secondary prevention, particularly in countries with low per capita incomes but also in wealthier nations, a new analysis shows. The study combined data ...